45
Participants
Start Date
January 31, 2000
Primary Completion Date
July 31, 2008
Study Completion Date
June 30, 2010
B-type Natriuretic Peptide (BNP)
BNP hormone self-administered subcutaneously twice daily for 8 weeks at 10 mcg/kg.
Placebo
Placebo self-administered subcutaneously twice daily for 8 weeks.
Mayo Clinic, Rochester
American Heart Association
OTHER
Scios, Inc.
INDUSTRY
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Center for Research Resources (NCRR)
NIH
Horng Chen
OTHER